Next Article in Journal
Design and Development of a New Methodology Based on Expert Systems Applied to the Prevention of Indoor Radon Gas Exposition Risks
Next Article in Special Issue
A Bibliometric Network Analysis of Coronavirus during the First Eight Months of COVID-19 in 2020
Previous Article in Journal
The Effect of Surrounding Greenness on Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort in Taiwan
Previous Article in Special Issue
How Big Data and Artificial Intelligence Can Help Better Manage the COVID-19 Pandemic
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Artificial Intelligence Model of Drive-Through Vaccination Simulation

1
Disaster & Emergency Management, School of Administrative Studies, York University, Toronto, ON M3J 1P3, Canada
2
Advanced Disaster, Emergency and Rapid Response Simulation (ADERSIM), York University, Toronto, ON M3J 1P3, Canada
3
Department of Mathematics and Statistics and Laboratory for Industrial and Applied Mathematics, York University, Toronto, ON M3J 1P3, Canada
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2021, 18(1), 268; https://doi.org/10.3390/ijerph18010268
Submission received: 16 October 2020 / Revised: 21 December 2020 / Accepted: 23 December 2020 / Published: 31 December 2020
(This article belongs to the Special Issue Big Data and Mathematical Modeling in Biomedicine)

Abstract

:
Planning for mass vaccination against SARS-Cov-2 is ongoing in many countries considering that vaccine will be available for the general public in the near future. Rapid mass vaccination while a pandemic is ongoing requires the use of traditional and new temporary vaccination clinics. Use of drive-through has been suggested as one of the possible effective temporary mass vaccinations among other methods. In this study, we present a machine learning model that has been developed based on a big dataset derived from 125K runs of a drive-through mass vaccination simulation tool. The results show that the model is able to reasonably well predict the key outputs of the simulation tool. Therefore, the model has been turned to an online application that can help mass vaccination planners to assess the outcomes of different types of drive-through mass vaccination facilities much faster.

1. Introduction

Since the COVID-19 pandemic started, efforts for vaccine development and production began in many different countries. It is argued that an effective vaccine can be the best solution to end and minimize the impacts of the pandemic. While some countries have already started vaccine testing and production, it is estimated that approved vaccination solutions for large-scale implementation can be ready as soon as January 2021 or even earlier [1]. Once a vaccine becomes available, the next challenge would be the vaccination of large numbers of people in a short period of time to minimize further human and economic impacts of the pandemic [2,3]. Rapid mass vaccination requires many local vaccination clinics. Considering that a vaccine will become available for the general public use in the near future, it is important to start planning ahead of time to be able to implement mass vaccination effectively and efficiently [4]. Therefore, access to mass vaccination modeling and simulation tools has become very important for public health units that are going to plan, manage and run different types of mass vaccination facilities.
Use of drive-through vaccination has been tested during past public health emergencies such as the H1N1 and during the COVID-19 pandemic for rapid testing and it has shown some promising outcomes [5,6]. A significant advantage of the drive-through clinics is their lower virus transmission possibility compared to walk-in clinics because people are isolated in their cars and are not in direct contact with other people [7]. They are only in contact with the immunization staff that are likely vaccinated first and are equipped with personal protection equipment. However, studies show that rapid vaccination using drive-through clinics requires proper site selections and design, human resources management, and careful attention to operational and logistical details [8].
COVID-19 mass vaccination can be implemented using a combination of traditional approaches such as health clinics, pharmacies, nursing homes, schools, workplaces, places of worship, and innovative and temporary facilities such as drive-through and large stadiums, and parking lots. Use of large temporary facilities allows for rapid and safer mass vaccination [9]. Drive-through facilities have lower disease transmission, low virus exposure, have large throughput, provide better security, and are more accessible and comfortable particularly for individuals with mobility issues or are geographically dispersed [2,7,10,11,12]. The drive-through method has some limitations and shortcomings as its usage is influenced by weather conditions, requires suitable and available spaces, and significant logistical planning. Moreover, drive-through can cause traffic issues in the localities and may expose staff to carbon monoxide exposure [6]. Despite these, drive-through facilities for mass vaccinations are recommended and are being seriously considered as part of the COVID-19 immunization process [13].
Drive-through vaccination was largely used in the USA in 2009 during the H1N1 influenza pandemic. Subsequent studies found that with reasonable processing time and negligible carbon monoxide exposure, drive-through is a feasible and effective alternative to traditional walk-in clinics by providing faster vaccination under lower disease transmission risks [14,15]. Drive-through clinics have been used for testing and provision of health services such as prenatal and pharmacy services during the COVID-19 pandemic as well [16,17,18,19]. The use of drive-through during the COVID-19 pandemic demonstrated its effectiveness in the absence of enough clinical testing facilities [20].
Drive-through mass vaccination facilities can be designed and implemented in various shapes and sizes [7,19,21,22,23]. Drive-through facilities with more dispensing lanes can provide higher throughputs and prevent traffic overflow onto neighboring streets [10,24]. Drive-through facilities need to be staffed with different skills including immunization, nursing, admin, IT, logistics, and security. Drive-through clinics can be set to work 24 h a day in two, three, or four shifts. Although drive-throughs have lower disease transmission risks, especially when staff and visitors use personal protective equipment and are vaccinated before vaccinating others, attention must be paid to the safety and the security issues related to traffic, drivers’ behaviors, and extreme weather conditions. Hence, large drive-through clinics may need to be supported by local emergency services such as police, fire, and paramedics [18,25,26].
Several studies have modeled and examined mass vaccination and point of dispensing clinics using discrete event, agent-based, optimization modeling, and multi-criteria decision support systems for better layout, efficiency, resource allocation, and scheduling [2,10,22,26,27,28,29,30,31]. Some of these models have been turned into software packages and tools. Examples of such tools included Clinic Planning Model Generator developed by Aaby et al. [22], Maxi-Vac by the US Centers for Disease Control, and Real Opt by Lee et al. [10]. However, new models and tools are needed to incorporate the specific challenges posed by the COVID-19 pandemic and emerging technological solutions in simulations and artificial intelligence. This paper aims to use the advancements in simulation tools and artificial intelligence to develop an application that can help mass vaccination planners to quickly assess potential outputs of different drive-through mass vaccination clinics.

2. Materials and Methods

The artificial intelligence (AI) discussed here was developed based on a big dataset derived from an existing drive-through mass vaccination simulation created by the authors [32]. In this section, we briefly explain the drive-through simulation tool and then provide some details about our machine learning model.

2.1. The Drive-Through Simulation

The drive-through model used in this study is a hybrid model consisting of a discrete event and an agent-based simulation. The model contains several agents including passengers, staff, and cars. The physical layout of the drive-through (Figure 1) can be extended up to ten lanes with a maximum area of 20,000 (150 m by 130 m). Passengers entering the drive-through are screened at the screening station to ensure that they meet the vaccination criteria and receive the necessary handout materials. Cars and passengers passed the screening phase move to one of the open lanes for registration, vaccination, and recovery, which can be determined in part by the availability of High Occupancy Vehicle Lane and Pre Registered Lanes. Vaccination will be conducted by professional immunization staff at the vaccination stations. Cars move to one of the available parking spaces located after the vaccination stations. Individuals experiencing complications after vaccination can be taken care of by the relevant staff. Each station is supported by up to four kiosks.
The discrete event model of the drive-through simulation generates the service process for each lane from registration to recovery (Figure 2). Start and end time in each station is measured through time blocks (for example, timer and timeRe refer to the start and end time for registration respectively).
A sample of our drive-through simulation experiment results is presented here. Table 1 shows the parameters setting for the experiment and Figure 3 presents the output of the experiment. The values presented in Figure 3 are the average of 50 iterations of this experiment. According to these results, a total of 1933 cars with 5804 passengers will be processed in the drive-through mass vaccination during a day with three shifts of 8 h each.

2.2. The AI Model

The high fidelity AnyLogic model suffers at inference time, due to the computation cost of running the simulation. A single simulation run can take up to 90 s, which may not be efficient in any real time analysis tasks. Due to the stochastic nature of the drive-through simulation, a significant number of simulations runs (using Monte Carlo method) is needed for each parameter setting that requires more simulation time. In order to alleviate this, we attempt to train a neural network to predict the outputs of the simulation based on the model parameters.
As is often the case with training neural networks, the problem is rooted in gathering large amounts of data on which to train. For this, we make use of the AnyLogic parallelized computation ability, to simulate large batches of simulation runs at the same time. In doing so, we strategically sample across a large range of parameters, near the domain of interest required of real-world scenarios. Parameter simulation ranges can be found in Table 2.
We chose to sample all variables uniformly, as we do not have any distribution knowledge of the real-world application of the model. Furthermore, by sampling in such an unbiased fashion, we reduce the chances of the network overfitting based on some intrinsic property of our training set. Some conditional restrictions are built regarding the binary variables, as noted in Table 1. Altogether, we generated about 125 k simulation samples, providing us with a dense enough training domain.

3. Results

We utilized an 80–20 train-test split to train a 5-layer feed forward neural network, which is shown in Figure 4. We trained the network using the Adam optimizer with a learning rate of 0.001, minimizing the mean absolute error, in batches of 256. Training was stopped after 100 epochs, with the test and validation error displayed in Figure 5.
Our final network is 10 Mb in size, which is small enough to be implemented even on the smallest of mobile devices and is able to infer results instantly. More precisely, by entering the parameters (within reasonable ranges) listed in Table 1, our model is able to predict information such as cars and passengers passing through the vaccination center, average wait times throughout the day and overall completion metrics. An example of this can be seen in Figure 6.
Our neural network model is capable of prediction orders of magnitudes faster than the full simulation model. More precisely, predictions were on average computed in 0.027 s, with minimum and maximum times of 0.025 and 0.039 s, respectively, in a simulation of 1000 random input variations. Distribution of the results can be seen in Figure 7. Notice that the time scale we achieve here is on the order of milliseconds, whereas previously we required minutes to produce these same results. We achieve an improvement of over 3000× in terms of speed, largely due to the computation cost of simulating the entire event. Furthermore, we do all this locally as opposed to the need for cloud computation.

4. Discussion

The drive-through model developed in this study is a meta-model (or models of models) that as described by Obsie et al. [33], represents a deterministic proxy for stochastic simulation models. However, developing this type of meta-models requires running complex simulation for many combinations and then using the data generated by each run to create a simpler machine learning model that is a reasonable approximation of the initial simulation model. The meta-models can then provide quick predictions for different input values. While simulation-based or meta-modeling is not a new concept [34], its application in different fields and simulation types are still limited. In this study, we applied meta-modeling approach in the context of mass vaccination.
The AI-based drive-through model developed here has been deployed as a web-application that can be used by potential users (www.adersim.org). The approach serves our purpose of providing a general decision supporting tool for planning a large-scale drive-through vaccination. A general decision unit, such as a municipal government or a public health region, may simply input its unique parameters, and our model will generate accurate prediction of waiting time, capacity, etc., very quickly. Since our AI model is much faster than the simulation model, municipal governments or public health regions may compare multiple decisions, regarding the number of lanes, staffing levels, etc., and make the best choice. Further, our AI model is as small as 10 Mb, which can be implemented on any mobile device as well.
Our drive-through simulation has been developed and parameterized based on the past and current best practices available for drive-through design, settings, and operations. However, because the details of a potential SARS-Cov-2 vaccination protocols are not available yet, our drive-through mass vaccination simulation tool can be further tuned as new information becomes available. For example, the vaccination and recovery times may be very much influenced by the specific immunization protocols for SARS-Cov-2 vaccine, which may be different from previous vaccination. In the absence of real drive-through cases, such simulations can play a significant role in pre-planning.
Another potential application of our method in the mass immunization case would be an extension of this approach for other mass vaccination clinics such as large temporary walk-in clinics that is currently under development by the authors. In future, we would like to further refine our neural network to further reduce its complexity and enhance its accuracy. More importantly, it will be interesting to see whether the same network will serve more general cases as they arise in future.

5. Conclusions

Drive-through clinics may be able to play a significant role in SARS-Cov-2 mass vaccination process as they provide a faster and safer options, as proven to be effective for SARS-Cov-2 testing in different countries. As such, drive-through option can complement other traditional and new mass immunization methods.
In this paper, we demonstrated how data generated from a simulation can be used to develop a new and better predictive machine learning model for drive-through mass vaccination clinics. The generated model can be used to obtain quick predictions of the number of people to be vaccinated and the average time it takes for vaccination under various parameter settings. The results show promising outcomes in applying this method in other aspects of pandemic management where large numbers of simulations are developed for prediction. Most of these simulations have the potential to be further enhanced and turned into artificial intelligence models that can help end users and policy makers to assess the impacts of various policy options.

Author Contributions

J.W., A.A. and M.C. conceived the idea. A.A. and M.M.N. developed the simulation model. S.Z.V. developed the AI model with feedback from M.C. and A.A. S.Z.V. and A.A. drafted the manuscripts. J.W. and M.M.N. reviewed the manuscript and made intellectual input. All authors have read and agreed to the published version of the manuscript.

Funding

Public Health Agency of Canada; Canadian Institute of Health Research, Ontario; Research Funds, National Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to its huge size.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. DeRoo, S.S.; Pudalov, N.J.; Fu, L.Y. Planning for a COVID-19 Vaccination Program. JAMA 2020, 323, 2458. [Google Scholar] [CrossRef] [PubMed]
  2. Gupta, A.; Evans, G.W.; Heragu, S.S. Simulation and optimization modeling for drive-through mass vaccination—A generalized approach. Simul. Model. Pr. Theory 2013, 37, 99–106. [Google Scholar] [CrossRef] [Green Version]
  3. Clemente-Suárez, V.J.; Hormeño-Holgado, A.; Jiménez, M.; Benitez-Agudelo, J.C.; Navarro-Jiménez, E.; Perez-Palencia, N.; Maestre-Serrano, R.; Laborde-Cárdenas, C.C.; Tornero-Aguilera, J.F. Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic. Vaccines 2020, 8, 236. [Google Scholar] [CrossRef] [PubMed]
  4. Gottlieb, S.; Rivers, C.; McClellan, M.; Silvis, L.; Watson, C. National Coronavirus Response: A ROAD map to Reopening; American Enterprise Institute: Washington, DC, USA, 2020; Available online: https://www.aei.org/research-products/report/national-coronavirus-response-a-road-map-to-reopening (accessed on 11 November 2020).
  5. Reid, D.E. What Are the Efficiencies of a Mass Vaccination Drive-Through Clinic Compared to a Walk-In Clinic? National Fire Academy: Emmitsburg, MD, USA, 2010; Available online: https://www.hsdl.org/?abstract&did=804516 (accessed on 11 November 2020).
  6. Wiggers, J.; van de Kracht, T.; Gupta, A.; Heragu, S.S. Design and Analysis of a Simulation Model for Drive-Through Mass Vaccination. In Proceedings of the 2011 Industrial Engineering Research Conference, Gujarat, India, 17 November 2011. [Google Scholar]
  7. Weiss, E.A.; Ngo, J.; Gilbert, G.H.; Quinn, J.V. Drive-Through Medicine: A Novel Proposal for Rapid Evaluation of Patients During an Influenza Pandemic. Ann. Emerg. Med. 2010, 55, 268–273. [Google Scholar] [CrossRef] [PubMed]
  8. Yaylali, E.; Ivy, J.S.; Taheri, J. Systems Engineering Methods for Enhancing the Value Stream in Public Health Preparedness: The Role of Markov Models, Simulation, and Optimization. Public Health Rep. 2014, 129, 145–153. [Google Scholar] [CrossRef] [PubMed]
  9. Schoch-Spana, M.; Brunson, E.; Long, R.; Ravi, S.; Ruth, A.; Trotochaud, M. The Public’s Role in COVID-19 Vaccination: Planning Recommendations Informed by Design Thinking and the Social, Behavioral, and Communication Sciences; Johns Hopkins Center for Health Security: Baltimore, MD, USA, 2020; Available online: https://www.centerforhealthsecurity.org/our-work/publications/the-publics-role-in-covid-19-vaccination (accessed on 11 November 2020).
  10. Lee, E.K.; Pietz, F.; Benecke, B.; Mason, J.; Burel, G. Advancing Public Health and Medical Preparedness with Operations Research. Interfaces 2013, 43, 79–98. [Google Scholar] [CrossRef]
  11. Carrico, R.M.; McKinney, W.P.; Watson, J.N.A.; Wiemken, T.; Myers, J. Drive-thru influenza immunization: Fifteen years of experience. J. Emerg. Manag. 2012, 10, 228. [Google Scholar] [CrossRef]
  12. Flynn, E.F.; Kuhn, E.; Shaik, M.; Tarr, E.; Scattolini, N.; Ballantine, A. Drive-Through COVID-19 Testing During the 2020 Pandemic: A Safe, Efficient, and Scalable Model for Pediatric Patients and Health Care Workers. Acad. Pediatr. 2020, 20, 753–755. [Google Scholar] [CrossRef]
  13. Stockley, S.; King, K.; Leach, J. Delivering Mass Vaccinations During COVID-19. A Logistical Guide for General Practice; Royal College of General Practitioners: London, UK, 2020; Available online: https://www.rcgp.org.uk/-/media/Files/Policy/A-Z-policy/2020/covid19/RCGP-guidance/RCGP-Mass-Vaccination-at-a-time-of-COVID-V15.ashx (accessed on 11 November 2020).
  14. Shim, E.; Meyers, L.A.; Galvani, A.P. Optimal H1N1 vaccination strategies based on self-interest versus group interest. BMC Public Health 2011, 11, S4. [Google Scholar] [CrossRef] [Green Version]
  15. Nicola, M.; Sohrabi, C.; Mathew, G.; Kerwan, A.; Al-Jabir, A.; Griffin, M.F.; Agha, M.; Agha, R. Health policy and leadership models during the COVID-19 pandemic: A review. Int. J. Surg. 2020, 81, 122–129. [Google Scholar] [CrossRef]
  16. Hussain, R.; Dawoud, D.; Babar, Z.-U.-D. Drive-thru pharmacy services: A way forward to combat COVID-19 pandemic. Res. Soc. Adm. Pharm. 2021, 17, 1920–1924. [Google Scholar] [CrossRef] [PubMed]
  17. Qeadan, F.; Honda, T.; Gren, L.H.; Dailey-Provost, J.; Benson, L.S.; Vanderslice, J.A.; Porucznik, C.A.; Waters, A.B.; Lacey, S.; Shoaf, K. Naive Forecast for COVID-19 in Utah Based on the South Korea and Italy Models-the Fluctuation between Two Extremes. Int. J. Environ. Res. Public Health 2020, 17, 2750. [Google Scholar] [CrossRef] [PubMed]
  18. Turrentine, M.; Ramirez, M.; Monga, M.; Gandhi, M.; Swaim, L.; Tyer-Viola, L.; Birsinger, M.; Belfort, M. Rapid Deployment of a Drive-Through Prenatal Care Model in Response to the Coronavirus Disease 2019 (COVID-19) Pandemic. Obstet. Gynecol. 2020. [Google Scholar] [CrossRef] [PubMed]
  19. Bailey, L.C.; Barrett, N.R.; Thorne, M.; Ford, F.M.; Elizabeth, W.; Psevdos, G. Successful Drive-thru Point-of-Distribution Influenza Vaccination Program for Veterans Affairs Medical Center Employees. Am. J. Infect. Control. 2020, 48, S31. [Google Scholar] [CrossRef]
  20. Lee, D.; Lee, J. Testing on the move: South Korea’s rapid response to the COVID-19 pandemic. Transp. Res. Interdiscip. Perspect. 2020, 5, 100111. [Google Scholar] [CrossRef]
  21. Wessex Local Medical Committees. Operational Aspects of Influenza Immunisation 2020/21; Wessex Local Medical Committees: Hampshire, UK, 2020. [Google Scholar]
  22. Knox, C.; Davenport, D. Dispensing Emergency Medications and Supplies. In Public Health Practice; Fielding, J.E., Teutsch, S.M., Eds.; Oxford University Press (OUP): Oxford, UK, 2012; pp. 243–253. [Google Scholar]
  23. Aaby, K.; Abbey, R.L.; Herrmann, J.W.; Treadwell, M.; Jordan, C.S.; Wood, K. Embracing Computer Modeling to Address Pandemic Influenza in the 21st Century. J. Public Health Manag. Pr. 2006, 12, 365–372. [Google Scholar] [CrossRef] [Green Version]
  24. Pate, J. Drive-Thru PODs: An Alternate Method of Mass Prophylaxis; Public Health Meeting: Washington, DC, USA, 2007. [Google Scholar]
  25. Beeler, M.F.; Aleman, D.M.; Carter, M.W. A simulation case study to improve staffing decisions at mass immunization clinics for pandemic influenza. J. Oper. Res. Soc. 2014, 65, 497–511. [Google Scholar] [CrossRef]
  26. Fryhofer, S.A.; Fryhofer, G.W. Vaccination-Induced Bursitis: Technique Matters. Ann. Intern. Med. 2020, 173, 308–310. [Google Scholar] [CrossRef]
  27. Hupert, N.; Mushlin, A.I.; Callahan, M.A. Modeling the Public Health Response to Bioterrorism: Using Discrete Event Simulation to Design Antibiotic Distribution Centers. Med. Decis. Mak. 2002, 22, 17–25. [Google Scholar] [CrossRef]
  28. Hupert, N.; Xiong, W.; King, K.; Castorena, M.; Hawkins, C.; Wu, C.; Muckstadt, J.A. Uncertainty and Operational Considerations in Mass Prophylaxis Workforce Planning. Disaster Med. Public Health Prep. 2009, 3, S121–S131. [Google Scholar] [CrossRef]
  29. Hernandez, I.; Ramirez-Marquez, J.E.; Starr, D.; McKay, R.; Guthartz, S.; Motherwell, M.; Barcellona, J. Optimal staffing strategies for points of dispensing. Comput. Ind. Eng. 2015, 83, 172–183. [Google Scholar] [CrossRef]
  30. Ramirez-Nafarrate, A.; Lyon, J.D.; Fowler, J.; Araz, O.M. Point-of-Dispensing Location and Capacity Optimization via a Decision Support System. Prod. Oper. Manag. 2015, 24, 1311–1328. [Google Scholar] [CrossRef]
  31. Hudgeons, A. Dispensing Medical Countermeasures in Public Health Emergencies via Home Health Agencies and Points of Distribution. Master’s Thesis, University of Arkansas, Fayetteville, AR, USA, 2018. Available online: http://scholarworks.uark.edu/ineguht/59 (accessed on 11 November 2020).
  32. Asgary, A.; Najafabadi, M.M.; Karsseboom, R.; Wu, J. A Drive-through Simulation Tool for Mass Vaccination during COVID-19 Pandemic. Healthcare 2020, 8, 469. [Google Scholar] [CrossRef] [PubMed]
  33. Obsie, E.Y.; Qu, H.; Drummond, F. Wild blueberry yield prediction using a combination of computer simulation and machine learning algorithms. Comput. Electron. Agric. 2020, 178, 105778. [Google Scholar] [CrossRef]
  34. Sanchez, S.M.; Sanchez, P.J.; Wan, H. Work smarter, not harder: A tutorial on designing and conducting simulation experiments. In Proceedings of the 2018 Winter Simulation Conference (WSC), Gothenburg, Sweden, 9–12 December 2018; Institute of Electrical and Electronics Engineers (IEEE): Piscataway, NJ, USA, 2018; pp. 237–251. [Google Scholar]
Figure 1. The 2D layout (a) and 3D (b) of the drive-through mass vaccination simulation tool (available at: https://cloud.anylogic.com/model/583c2075-6a8b-41be-8a03-d692eba71683).
Figure 1. The 2D layout (a) and 3D (b) of the drive-through mass vaccination simulation tool (available at: https://cloud.anylogic.com/model/583c2075-6a8b-41be-8a03-d692eba71683).
Ijerph 18 00268 g001aIjerph 18 00268 g001b
Figure 2. The service lanes flowchart of the drive-through mass vaccination simulation tool.
Figure 2. The service lanes flowchart of the drive-through mass vaccination simulation tool.
Ijerph 18 00268 g002
Figure 3. Sample simulation results for number of cars and passengers using the drive-through (a) and average time spent in the drive-through (b) based on drive-through settings in Table 1.
Figure 3. Sample simulation results for number of cars and passengers using the drive-through (a) and average time spent in the drive-through (b) based on drive-through settings in Table 1.
Ijerph 18 00268 g003
Figure 4. Each layer in our network model consists of a fully connected tensor with a Relu activation function. The first four all utilize a 20% dropout layer for regularization, while the final feature layer does not.
Figure 4. Each layer in our network model consists of a fully connected tensor with a Relu activation function. The first four all utilize a 20% dropout layer for regularization, while the final feature layer does not.
Ijerph 18 00268 g004
Figure 5. Test (blue) and validation (yellow) set errors over the course of training through 100 epochs. Validation error seems to level off around 50 epochs in.
Figure 5. Test (blue) and validation (yellow) set errors over the course of training through 100 epochs. Validation error seems to level off around 50 epochs in.
Ijerph 18 00268 g005
Figure 6. Example of our model predictions for a set of input parameters. All time data is sampled on 10 min intervals but can easily be adjusted for finer grain information. Wait time distributions align with pre-observed results directly from the AnyLogic model. Red line represents mean wait time.
Figure 6. Example of our model predictions for a set of input parameters. All time data is sampled on 10 min intervals but can easily be adjusted for finer grain information. Wait time distributions align with pre-observed results directly from the AnyLogic model. Red line represents mean wait time.
Ijerph 18 00268 g006
Figure 7. Computation times across 1000 random input samples using our fully trained neural network model.
Figure 7. Computation times across 1000 random input samples using our fully trained neural network model.
Ijerph 18 00268 g007
Table 1. Parameter settings for the sample drive-through simulation experiment.
Table 1. Parameter settings for the sample drive-through simulation experiment.
ParametersValue
Lane 1-Lane10Open
Minimum number of passengers in cars1
Maximum number of passengers in cars5
Number of cars coming to drive through per min5
Average registration time (min)4.24
Average vaccination time (min)3.26
Average recovery time (min)4
Number of staff in each station in lane 1-lane104
Assign High Occupancy Lanes (HOV)FALSE
Fraction of cars pre-registered for vaccination (0–1)50
Pre-registration impact factor (0–1)0.5
Consider pre-registrationTRUE
Low occupancy vehicleFALSE
Fraction of non-adult passengers0.15
Fraction of cars rejected at screening0.01
Shift hours8
Number of shifts3
Average screening time 0.5
Minimum screening time0.25
Maximum screening time0.5
Dynamically learn and adjust cars going to each laneTRUE
Use schedule for incoming carsFALSE
Table 2. Parameter sampling ranges for model training.
Table 2. Parameter sampling ranges for model training.
ParameterRangeNotes
Average recovery time (min)5–10
Average registration time (min)2–7
Average screening time0.25–1
Maximum screening time1fixed
Minimum screening time0.25fixed
Average vaccination time (min)2–7
Maximum number of passengers in cars5–7integer only
Minimum number of passengers in cars1fixed
Fraction of non-adult passengers0.15–0.30
Number of cars coming to drive through per minute0.5–5
Fraction of cars rejected at screening0.01fixed
Shift hours6, 8 or 12
Number of shifts2, 3 or 4Depending on shift hours such that total hours = 24
Days1fixed
Lanes 1–10True or FalseAt least 1 lane is always open
Number of staff in each lane1–4Can differ lane to lane, integer only
Consider pre-registrationTrue or False
Assign High Occupancy Lanes (HOV)True or False
Dynamically learn and adjust cars going to each laneTrue or FalseCan only be true if HOV is open
Low occupancy vehicleTrue or FalseCan only be true if HOV is open
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Asgary, A.; Valtchev, S.Z.; Chen, M.; Najafabadi, M.M.; Wu, J. Artificial Intelligence Model of Drive-Through Vaccination Simulation. Int. J. Environ. Res. Public Health 2021, 18, 268. https://doi.org/10.3390/ijerph18010268

AMA Style

Asgary A, Valtchev SZ, Chen M, Najafabadi MM, Wu J. Artificial Intelligence Model of Drive-Through Vaccination Simulation. International Journal of Environmental Research and Public Health. 2021; 18(1):268. https://doi.org/10.3390/ijerph18010268

Chicago/Turabian Style

Asgary, Ali, Svetozar Zarko Valtchev, Michael Chen, Mahdi M. Najafabadi, and Jianhong Wu. 2021. "Artificial Intelligence Model of Drive-Through Vaccination Simulation" International Journal of Environmental Research and Public Health 18, no. 1: 268. https://doi.org/10.3390/ijerph18010268

APA Style

Asgary, A., Valtchev, S. Z., Chen, M., Najafabadi, M. M., & Wu, J. (2021). Artificial Intelligence Model of Drive-Through Vaccination Simulation. International Journal of Environmental Research and Public Health, 18(1), 268. https://doi.org/10.3390/ijerph18010268

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop